Submission to the Pharmaceutical Benefits Advisory Committee (PBAC) PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types
Autor: | Tuffaha, Haitham W, Scuffham, Paul |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
DOI: | 10.13140/rg.2.2.32950.60489 |
Databáze: | OpenAIRE |
Externí odkaz: |